Aug 2026
In situ-formed pH-responsive hydrogel for sequential vascular disruption and Type I sonodynamic therapy-driven PANoptosis in hypoxic tumor therapy.
This work presents an in situ-formed pH-responsive injectable hydrogel platform that integrates controlled drug release, Type I sonodynamic PANoptosis, and immune activation for enhanced antitumor immunotherapy.
Kexin Wen, Chenxi Zhang, Qin Fan et al.
· Journal of Controlled Releas... · 0 citations